Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Partners discuss FTC rulemaking, litigation at direct selling seminar

Ohio Clock

Hallway with a grandfather clock displayed

The Weekly Hill Update

PDMI Take 20: AI Series, Ep. 2 — Regulatory Implications

Artificial Intelligence

Blockchain Monitor

Crypto Products Launch for Custody, Tokenization, Staking; Crypto Adoption Report Published; DFS Proposes New VC Guidance; NFT Initiatives Announced

As announced on June 9, 2022, Partner Adam Finerman and BakerHostetler represented Pulse Biosciences Inc. in a public rights offering pursuant to which Pulse sold more than 7 million units for an aggregate of more than $15 million, with each unit consisting of one share and one warrant to purchase a share. Pulse Biosciences is a bioelectric medicine company commercializing its CellFX® System, powered by Pulse’s proprietary Nano-Pulse Stimulation™. Initial commercial use of the CellFX System has been in dermatologic conditions.  <a href="https://www.businesswire.com/news/home/20220609006029/en/">More information</a>

Adam Finerman Represents Pulse Biosciences in Public Rights Offering

Featured Insights

Related Services

Featured Insights